Kubik, Grzegorz Dr.

Head of the Industrial Biotechnology Innovation Field

Dr. Grzegorz (Greg) Kubik has made it his mission to transform the chemical industry into a more environment-friendly one by implementating biotechnological methods. He is a trained chemist with more than 10 years of interdisciplinary experience in the field of biotechnology in various international positions as a scientist, project manager and business development manager both in science and industry. Since July 2021 he is the head of the Innovation Field Industrial Biotechnology at Fraunhofer IGB.

  • Professional career

    Since 07/2021 Head of Innovation Field Industrial Biotechnology at Fraunhofer IGB
    07/2020 – 06/2021  Senior Manager Business Development with Synbionik GmbH
    01/2019 – 07/2020  Business Development Manager with Enzymaster Deutschland GmbH
    06/2016 – 05/2018  Postdoctoral Researcher at Caltech with Frances H. Arnold
    10/2012 – 01/2016  PhD in Chemistry at University of Konstanz and Konstanz Research School Chemical Biology
    10/2007 – 07/2012 Studies in Chemistry at RWTH Aachen University with specialization in organic chemistry, catalysis and industrial chemistry
  • [12]  Giess M., Munoz-Lopez A., Buchmuller B., Kubik G., Summerer D., „Programmable Protein-DNA Crosslinking for the Direct Capture and Quantification of 5-Formylcytosine”, J. Am. Chem. Soc. 2019, 141 (24), 9453-9547. 

    [11] Hammer S.C., Kubik G., Watkins E.J., Minges H., Huang S., Arnold F.H., „Anti-Markovnikov alkene oxidation by metal-oxo-mediated enzyme catalysis”, Science 2017, 358, 215-218. (Highlighted in “Research of the Year”, C&EN 2017, 95 (49), 19 and Synfacts 2018, 14 (1), 83.)

    [10]  Flade S., Jasper J., Giess M., Juhasz M., Dankers A., Kubik G., Koch O., Weinhold E., Summerer D., The N6-Position of Adenine is a Blind Spot for TAL-Effectors that Enables Effective Binding of Methylated and Fluorophore-Labeled DNA”, ACS Chem. Biol. 2017, 12 (7), 1719–1725.

     [9]  Rathi P., Maurer S., Kubik G., Summerer D., „Isolation of Human Genomic DNA Sequences with Expanded Nucleobase Selectivity”, J. Am. Chem. Soc. 2016, 138 (31), 9910–9918.

    [8]   Kubik G., Summerer D., „TALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis”, ChemBioChem 2016, 17 (11), 975-980.

    [7]   Kubik G., Summerer D., „Deciphering Epigenetic Cytosine Modifications by Direct Molecular Recognition”, ACS Chem. Biol. 2015, 10, 1580-1589.

    [6]   Kubik G., Batke S., Summerer D., „Programmable Sensors of 5‑Hydroxymethylcytosine”, J. Am. Chem. Soc. 2015, 137 (1), 2-5.

    [5]   Kubik G., Summerer D., „Achieving single nucleotide resolution of 5‑methylcytosine detection with TALEs”, ChemBioChem 2015, 16 (2), 228-231.

    [4]   Kubik G., Schmidt M.J., Penner J.E., Summerer D., „Programmable and Highly Resolved in vitro Detection of 5-Methylcytosine by TALEs“, Angew. Chem. Int. Ed. 2014, 23, 6002-6006.

    [3]   Haven T., Kubik G., Haubenreisser S., Niggemann M., „Calcium Catalyzed Cyclopropanation”, Angew. Chem. Int. Ed. 2013, 14, 4016-4019. (Highlighted in Synfacts 2013, 9 (6), 619.)

    [2]   Ma G., Lin S., Ibrahem I., Kubik G., Liu L., Sun J., Córdova A., „Achiral Co-Catalyst Induced Switches in Catalytic Asymmetric Reactions on Racemic Mixtures (RRM): From Stereodivergent RRM to Stereoconvergent Deracemization by Combination of Hydrogen Bond Donating and Chiral Amine Catalysts”, Adv. Synth. Catal. 2012, 14-15, 2865–2872.

    [1]   Giese M., Albrecht M., Wiemer K., Kubik G., Valkonen A., Rissanen K., „Weak Intermolecular Anion–π Interactions in Pentafluorobenzyl-Substituted Ammonium Betaines“, Eur. J. Inorg. Chem. 2012, 18, 2995–2999.


    [3]   Hu Hu (胡虎), Marco Bocola (马克·博科拉), Grzegorz Kubik (格雷戈日·库比克), Chen Haibin (陈海滨), Jin Ou Ping (金炉萍), “Method for synthesizing R-3-(2-chloro-1-hydroxyethyl) phenol, phenylephrine, and eye drops” 2020, CN111378695A, filed by Enzymaster Ningbo Bio Engineering Co ltd. (Ausstehend)

    [2]   Summerer D., Kubik G., Giess M., Maurer S., “Transcription Activator-Like Effector (TALE)-based Decoding of Cytosine Nucleobases by Selective Modification Response2016, EP3214183 A1, filed by the University of Konstanz. (Erteilt)

    [1]   Summerer D., Kubik G., Schmidt M.J., “Direct, programmable detection of epigenetic cytosine modifications using TAL effectors2014, PCT/EP2014/001753, filed by the University of Konstanz. (Erteilt)


    [2]   Schiffels J., Kubik G., Dick M., „Synthetische Biologie: Mikroben für Cannabis‐Wirkstoffe“, Nachrichten aus der Chemie 2021, 69, 26-29.

    [1]   Kubik G., Chen H., Bocola M., Bong Y.K., Daußmann T., „Sustainable biocatalytic synthesis of β-hydroxy-α-amino acids on an industrial scale “, PharmaChem 2019, 5/6, 2-4.